Antimicrobial activity of mono- and polynuclear platinum and palladium complexes
Introduction. Infectious diseases remain a serious threat to humanity worldwide as bacterial pathogens grow more diverse. Bacteria, fungi, and parasites develop resistance to clinically approved antimicrobials, which reduces the efficacy of available drugs and treatment measures. As a result, there is an ever growing demand for new highly effective pharmaceuticals. This review describes mono- and polynuclear platinum and palladium complexes with antimicrobial properties. We compared several groups of antibacterial agents: antibiotics, antioxidant biologically active substances, antimicrobial nanoparticles, nanocomposite materials, biopolymers, micellar systems, and plant extracts. Study objects and methods. The review covered relevant articles published in Web of Science, Scopus, and Russian Science Citation Index for the last decade. The list of descriptors included such terms as mononuclear and binuclear complexes of platinum, palladium, and antimicrobial activity. Results and discussion. Chelates of platinum, palladium, silver, iridium, rhodium, ruthenium, cobalt, and nickel are popular therapeutic agents. Their antimicrobial activity against pathogenic microorganisms can be enhanced by increasing their bioavailability. Metalbased drugs facilitate the transport of organic ligands towards the bacterial cell. The nature of the ligand and its coordination change the thermodynamic stability, kinetic lability, and lipophilic properties of the complex, as well as the reactivity of the central atom. Polynuclear platinum and palladium complexes contain two or more bound metal (coordinate) centers. Covalent bonding with bacterial DNA enables them to form a type of DNA adducts, which is completely different from that of mononuclear complexes. Conclusion. Metal-based drugs with functional monodentate ligands exhibit a greater antimicrobial effect compared to free ligands. Poly- and heteronuclear complexes can increase the number of active centers that block the action of bacterial cells. When combined with other antibacterial agents, they provide a synergistic effect, which makes them a promising subject of further research.
Top-30
Journals
|
1
2
|
|
|
Proceedings of universities. Applied chemistry and biotechnology
2 publications, 10%
|
|
|
Antibiotics
1 publication, 5%
|
|
|
Crystals
1 publication, 5%
|
|
|
Journal of Physical Organic Chemistry
1 publication, 5%
|
|
|
Foods and Raw Materials
1 publication, 5%
|
|
|
Food Processing Techniques and Technology
1 publication, 5%
|
|
|
ACS Omega
1 publication, 5%
|
|
|
Science China Chemistry
1 publication, 5%
|
|
|
Russian Chemical Reviews
1 publication, 5%
|
|
|
Molecules
1 publication, 5%
|
|
|
Journal of Molecular Structure
1 publication, 5%
|
|
|
Journal of Organometallic Chemistry
1 publication, 5%
|
|
|
Applied Surface Science Advances
1 publication, 5%
|
|
|
Inorganica Chimica Acta
1 publication, 5%
|
|
|
International Journal of Biological Macromolecules
1 publication, 5%
|
|
|
Dalton Transactions
1 publication, 5%
|
|
|
Microorganisms
1 publication, 5%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
|
|
|
Elsevier
6 publications, 30%
|
|
|
MDPI
4 publications, 20%
|
|
|
Kemerovo State University
2 publications, 10%
|
|
|
Irkutsk National Research Technical University
2 publications, 10%
|
|
|
Wiley
1 publication, 5%
|
|
|
American Chemical Society (ACS)
1 publication, 5%
|
|
|
Springer Nature
1 publication, 5%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 5%
|
|
|
Research Square Platform LLC
1 publication, 5%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 5%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.